CALA
Closed
Calithera Biosciences Inc
0.0001
-0.0009 (-90.00%)
Last Update: 01 Jul 2025 16:30:00
Yesterday: 0.001
Day's Range: 0.0001 - 0.0001
Send
sign up or login to leave a comment!
When Written:
0.055
Calithera Biosciences Inc. is a clinical-stage biotechnology company that focuses on discovering and developing novel small molecule drugs that target enzymes and metabolic pathways involved in cancer and other diseases. The company's lead product candidate, CB-839, is an oral inhibitor of glutaminase, an enzyme that plays a key role in cancer cell metabolism. CB-839 is currently in Phase 2 clinical trials for the treatment of several types of cancer, including renal cell carcinoma, triple-negative breast cancer, and non-small cell lung cancer. Calithera Biosciences Inc. was founded in 2010 and is headquartered in South San Francisco, California.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








